Form 4: Medicine Man Technologies Director Brad Stewart Receives Stock Grant for Board Service

Sentiment:

SEC Form 4 Filing


Director Brad Stewart received 34,451 shares of Medicine Man Technologies stock valued at $28,250 for his service on the board.

Summary

  • Brad Stewart, a director of Medicine Man Technologies, Inc., received 34,451 shares of common stock on March 29, 2024.
  • The shares were granted as compensation for his service on the board of directors.
  • The aggregate value of the shares was $28,250, based on the closing price of the common stock on the OTCQX Best Market on March 28, 2024.
  • Following the transaction, Stewart beneficially owns 143,459 shares of Medicine Man Technologies.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock grant for board service). It's neutral to slightly positive as it aligns director interests with shareholders.

Positives

  • The stock grant aligns the director's interests with those of the shareholders.
  • The grant is a form of non-cash compensation, preserving cash for other business needs.

Future Outlook

There is no future outlook provided in this document.

Industry Context

Stock grants to board members are a common practice in publicly traded companies, including those in the cannabis industry, to align their interests with shareholders and incentivize performance.

Comparison to Industry Standards

  • Comparing the size of the stock grant to similar companies in the cannabis industry would provide context on whether the compensation is in line with industry standards.
  • Companies like Curaleaf, Trulieve, and Green Thumb Industries also use stock options and grants as part of their compensation packages for directors and executives.
  • Benchmarking against these companies would require analyzing their SEC filings to determine the value and structure of their equity-based compensation plans.

Stakeholder Impact

  • The stock grant could have a slightly positive impact on shareholders by aligning the director's interests with theirs.
  • The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/28/2024Date used to determine the closing price of the common stock on the OTCQX Best Market for valuation purposes.
03/29/2024Date of the transaction where Brad Stewart acquired shares.
04/02/2024Date of signature for the Form 4 filing.

Keywords

Medicine Man Technologies, Director Compensation, Stock Grant, Beneficial Ownership, Form 4, SHWZ, Brad Stewart, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.